Clinical Trial Update: A Study of Combination Therapy in NSCLC [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update for a combination therapy in non-small cell lung cancer; current status is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Chinese PLA General Hospital | Conditions: Non-small Cell Lung Cancer | Phase 2 | Status: UNKNOWN